J Hyg Epidemiol Microbiol Immunol
December 1985
As a part of preclinical trials of 2,996 clinical isolates from three larger hospitals in Prague were qualitatively and quantitatively assayed for in vitro sensitivity to ceftazidime. In gramnegative bacteria the incidence of resistance to ceftazidime in strain of Enterobacter, Serratia Proteus and Pseudomonas species ranged from 4% to 6% of strains. In grampositive bacteria only strains of enterococci, listeriae and anaerobic bacteria are excluded from the action of this broad-spectrum antibiotic.
View Article and Find Full Text PDFCesk Epidemiol Mikrobiol Imunol
November 1982
Cesk Epidemiol Mikrobiol Imunol
September 1979